Innovative Oral Immunology Awarded

Home page Description: 
UHN’s Dr. Michael Glogauer wins the prestigious 2024 CADR/ACFD National Research Award.
Posted On: June 24, 2024
Image Caption: 
Dr. Michael Glogauer, Dentist-in-Chief, Head of Dental Oncology, and Clinician Investigator at the Princess Margaret Cancer Centre.

UHN’s Dr. Michael Glogauer has been honoured with the 2024 CADR/ACFD National Research Award. This prestigious recognition highlights his contributions to the fields of oral health and immunology, particularly his game-changing research on neutrophils and their role in both oral and systemic diseases affecting the whole body. 

Dr. Glogauer's research has significantly advanced the understanding of neutrophil biology. Neutrophils are blood cells that are one of the body's first lines of defense. He identified a critical neutrophil subset that is instrumental in preventing infections in patients with neutropenia (abnormally low levels of neutrophils) and those undergoing bone marrow transplants.  

This work not only garnered international acclaim but also led to the development of innovative diagnostic techniques, including an oral rinse protocol to monitor immune function in patients undergoing chemotherapy. His research into the interactions between the oral microbiome and the innate immune system has provided profound insights into biofilm formation and dental plaque, impacting the broader field of oral microbiology. 

One of Dr. Glogauer's notable achievements is the establishment of Ostia Sciences, a biotech startup focused on the oral microbiome, probiotic development, and new antibiotics. His entrepreneurial spirit and dedication to translational research have facilitated significant advancements in the diagnostic and therapeutic approaches to oral health. Furthermore, his work has elucidated the molecular mechanisms linking periodontal diseases to systemic health conditions, such as heart disease and arthritis, highlighting the crucial interplay between oral health and overall well-being. 

Upon receiving the award, Dr. Glogauer said, "This recognition is not just a personal honour but a testament to the collaborative efforts of my colleagues and students. Our work aims to bridge the gap between oral and systemic health, ultimately improving patient outcomes through innovative research and clinical practice." 

Dr. Glogauer's commitment to education and collaboration is evident in his efforts to foster interdisciplinary studies and mentorship. His creation of the Schulich Dental Mini-MBA and Entrepreneurship program underscores his dedication to nurturing the next generation of dental professionals. His impact on the dental research community is profound, and his contributions continue to shape the future of oral health research and practice. 

For more information on the CADR/ACFD National Research Award and recipients past and present, click here.